Caprock Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Caprock Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,429	Closed	-$210K	–	610
2021 Q4	$210K	Buy	+3,429	New	+$237K	0.02%	527
2021 Q3	–	Sell	-2,566	Closed	-$237K	–	536
2021 Q2	$237K	Sell	2,566 -2,977	-54%	-$253K	0.02%	446
2021 Q1	$492K	Buy	5,543 +843	+18%	+$83.6K	0.05%	241
2020 Q4	$438K	Sell	4,700 -121	-3%	-$9.64K	0.05%	252
2020 Q3	$307K	Sell	4,821 -397	-8%	-$23.3K	0.04%	288
2020 Q2	$272K	Sell	5,218 -4,107	-44%	-$176K	0.04%	301
2020 Q1	$292K	Buy	+9,325	New	+$312K	0.06%	241

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Caprock Group's ARKG Position: Q1 2022 in Review

Caprock Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 3,429 shares — an estimated $210K sold.

Caprock Group first reported a position in ARKG in Q1 2020 and held it in 7 quarters. The position peaked at $492K in Q1 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Caprock Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Caprock Group sold 3,429 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $210K.
Caprock Group first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 7 quarters.
Caprock Group's ARK Genomic Revolution ETF position peaked at $492K in Q1 2021.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Caprock Group's 13F filing for Q1 2022, filed 12 Apr 2022.